Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Pharmaceuticals 2013, 6(5), 681-688; doi:10.3390/ph6050681
Review

Evolution of Biologics Screening Technologies

* ,
 and
Received: 5 February 2013; in revised form: 23 April 2013 / Accepted: 8 May 2013 / Published: 14 May 2013
(This article belongs to the Special Issue Biologics)
View Full-Text   |   Download PDF [134 KB, uploaded 14 May 2013]   |   Browse Figure
Abstract: Screening for biologics, in particular antibody drugs, has evolved significantly over the last 20 years. Initially, the screening processes and technologies from many years experience with small molecules were adopted and modified to suit the needs of biologics discovery. Since then, antibody drug discovery has matured significantly and is today investing earlier in new technologies that commercial suppliers are now developing specifically to meet the growing needs of large molecule screening. Here, we review the evolution of screening and automation technologies employed in antibody discovery and highlight the benefits that these changes have brought.
Keywords: high throughput screening; assay technologies; therapeutic antibodies high throughput screening; assay technologies; therapeutic antibodies
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Cariuk, P.; Gardener, M.J.; Vaughan, T.J. Evolution of Biologics Screening Technologies. Pharmaceuticals 2013, 6, 681-688.

AMA Style

Cariuk P, Gardener MJ, Vaughan TJ. Evolution of Biologics Screening Technologies. Pharmaceuticals. 2013; 6(5):681-688.

Chicago/Turabian Style

Cariuk, Peter; Gardener, Matthew J.; Vaughan, Tristan J. 2013. "Evolution of Biologics Screening Technologies." Pharmaceuticals 6, no. 5: 681-688.



Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert